A cancer trial has reportedly become the first in the world to completely remove the disease in every patient, according to a study published Sunday in the New England Journal of Medicine.
The study, titled “PD-1 Blockade in Mismatch Repair—Deficient, Locally Advanced Rectal Cancer” was conducted among 12 rectal cancer patients, all of which had a “clinical complete response,” according to the authors, led by Dr. Andrea Cercek of the Memorial Sloan Kettering Cancer Center, New York City.
Doctors have been unable to see any evidence of tumors among the patients when using magnetic resonance imaging, fludeoxyglucose F 18 injections, physical examinations, or via endoscopic evaluations, according to researchers…. » Read full article
Sperm Counts Halved, Is This Diet-Switch Triggering an Apocalypse?
Analysis by Ashley Armstrong Story at-a-glance Male fertility is declining sharply, with sperm counts dropping over 50% in the last 50 years The shift from saturated fats to polyunsaturated
